Open Access Open Access  Restricted Access Subscription Access

Nanotechnology Aspects in Pharmacy

Dipak Ratilal Garg, R. B. Lovhare, S. A. Patil, Y. B. Rokade, S. P. Pawar

Abstract


Materials in the nanoscale range are utilized as symptomatic devices or to manage restorative medications to explicit designated locales in a controlled way. Nanomedicines and nano delivery systems are relatively young but fast evolving fields of study. Through the site-specific and target-oriented administration of precise medications, nanotechnology provides numerous advantages in the treatment of chronic human diseases. These days, there are many excellent uses of nanomedicine (chemotherapeutic specialists, natural specialists, immunotherapeutic specialists, and so forth.) for treating a wide range of illnesses. This review provides an updated overview of recent developments in the field of nanomedicines and nano-based drug delivery systems by carefully examining the identification and use of nanomaterials to enhance the effectiveness of both new and existing


Full Text:

PDF

References


Pandey R, Khuller GK (2006). Nanotechnology based drug delivery system(s) for the management of tuberculosis.

N.K. Jain, Pharmaceutical Nanotechnology, Sagar, Dr. Hari Singh Gour University, 2007.

G.A. Mansoori, T. Rohani.B, A. Ahmadpour, Z. and Eshaghi, Environmental Application of Nanotechnology, Annual Review of Nano-Research, 2008; 2(2): 2. 3.

Peng Liu, Nano-crystal formulation for poorly soluble drugs, Finland, Helsinki University Printing House, 2013.

S. R. D’Mello, C. N. Cruz, M. L. Chen, M. Kapoor, S. L. Lee, and K. M. Tyner, “The evolving landscape of drug products containing nanomaterials in the United States, “Nature Nano-technology, vol. 12, no. 6, pp. 523–529, 20176)

V. P. Nguyen, H. Le Trung, T. H. Nguyen, D. Hoang, and T. Tran, “Synthesis of biogenic silver nanoparticles with eco-friendly processes using Ganoderma lucidum extract and evaluation of their transonic applications, “Journal of Nano-materials, vol. 2021, Article ID 6135920, 11 pages, 2021.

A. Di Paolo, “Liposomal anticancer therapy: pharmacokinetic and clinical aspects, “Journal of chemotherapy, vol. 16, supple-mint 4, pp. 90–93, 2004

K. M. Tyner, N. Zheng, S. Choi et al., “How has CDER pre-pared for the nano revolution? A review of risk assessment,regulatory research, and guidance activities, ”The AAPS Jour-nal, vol. 19, no. 4, pp. 1071–1083, 2017

Meng, E. and Hoang, T. (2012). Micro- and Nano-fabricated implantable drug-delivery systems. 3(12): 1457–1467

Sridhar, R. and Ramakrishna, S. (2013).Electro sprayed nanoparticles for drug delivery and pharmaceutical applications.Biomatter, 3, pp1-12.27.


Refbacks

  • There are currently no refbacks.